← Leaderboards
Robert N Golden
University Of North Carolina Chapel Hill
$31,944,665
Attributed
$31,944,665
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $14.9M · FY2005–23$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$40,934,547 · 11
By mechanism
C06$36,873,525 · 4
M01$4,061,022 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Fulton T Crews$34,208,071
- James A Swenberg$37,028,398
- Blossom A Damania$35,988,246
- Pierre Buekens$14,928,301
- Steven H Zeisel$43,160,126
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationMental Disorder ChemotherapyClinical DepressionDrug Screening /EvaluationSertralineChromiumCombination ChemotherapyDrug InteractionsClinical Trial Phase IDrug MetabolismBupropionPsychiatryHiv InfectionsPsychologyCase HistoryNeuropsychologyCopingMental Health EpidemiologyNervous System Disorder EpidemiologyOutcomes ResearchPatient Oriented ResearchMajor Depression
Grant awards (28)
A National, Theranostic Cyclotron Resource to Drive Fundamental and Translational Medical Science$8,000,000
C06 · FY2023 · OD · contact PI
Cardiovascular and Regenerative Sciences in WIMR Phase II$14,873,525
C06 · FY2010 · RR · contact PI
General Clinical Research Center$210,004
M01 · FY2007 · RR · contact PI
General Clinical Research Center$1,779,878
M01 · FY2006 · RR · contact PI
NIMH HUMAN GENETICS INITIATION$248
M01 · FY2006 · RR · contact PI
NIMH HUMAN GENETICS INITIATION$22,933
M01 · FY2005 · RR
EXTRAMURAL FACILITIES IMPROVEMENT PROGRAM$7,000,000
C06 · FY2004 · RR
NIMH Human Genetics Initiation$17,548
M01 · FY2004 · RR
Chromium Potentiation of Sertraline in Refractory Mood Disorders$1,981
M01 · FY2004 · RR
The Neurogenetics of Serotonin in Depression$283
M01 · FY2004 · RR
EXTRAMURAL FACILITIES IMPROVED PROGRAM PROJECTS$7,000,000
C06 · FY2003 · RR
COPING IN HEALTH AND ILLNESS PROJECT$190,747
M01 · FY2002 · RR
BUPROPION SR IN ATYPICAL DEPRESSION$190,747
M01 · FY2002 · RR
CHROMIUM POTENTIATION OF SERTRALINE IN REFRACTORY DYSTHYMIC DISORDER$190,747
M01 · FY2002 · RR
BUPROPION SR IN ATYPICAL DEPRESSION$294,555
M01 · FY2001 · RR
COPING IN HEALTH AND ILLNESS PROJECT$294,555
M01 · FY2001 · RR
CHROMIUM POTENTIATION OF SERTRALINE IN REFRACTORY DYSTHYMIC DISORDER$294,555
M01 · FY2001 · RR
COPING IN HEALTH AND ILLNESS PROJECT$190,747
M01 · FY2001 · RR
BUPROPION SR IN ATYPICAL DEPRESSION$190,747
M01 · FY2001 · RR
CHROMIUM POTENTIATION OF SERTRALINE IN REFRACTORY DYSTHYMIC DISORDER$190,747
M01 · FY2001 · RR
CHROMIUM POTENTIATION OF SERTRALINE IN REFRACTORY DYSTHYMIC DISORDER$0
M01 · FY2000 · RR
CHROMIUM POTENTIATION OF SERTRALINE IN REFRACTORY DYSTHYMIC DISORDER$0
M01 · FY2000 · RR
EFFICACY OF PREGABALIN IN PATIENTS WITH SOCIAL PHOBIA$0
M01 · FY2000 · RR
CHROMIUM POTENTIATION OF SERTRALINE IN REFRACTORY DYSTHYMIC DISORDER$0
M01 · FY2000 · RR
BUPROPION SR IN ATYPICAL DEPRESSION$0
M01 · FY2000 · RR
COPING IN HEALTH AND ILLNESS PROJECT$0
M01 · FY2000 · RR
EFFECSCY OF LU 26-054, CITALOPRAM IN MAJOR DEPRESSION$0
M01 · FY2000 · RR
CHROMIUM POTENTIATION OF SERTRALINE IN REFRACTORY DYSTHYMIC DISORDER$0
M01 · FY2000 · RR